Lewei Lin

3.1k total citations · 1 hit paper
76 papers, 2.1k citations indexed

About

Lewei Lin is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Lewei Lin has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Public Health, Environmental and Occupational Health, 31 papers in Epidemiology and 21 papers in Anesthesiology and Pain Medicine. Recurrent topics in Lewei Lin's work include Opioid Use Disorder Treatment (52 papers), Substance Abuse Treatment and Outcomes (28 papers) and Pain Management and Opioid Use (21 papers). Lewei Lin is often cited by papers focused on Opioid Use Disorder Treatment (52 papers), Substance Abuse Treatment and Outcomes (28 papers) and Pain Management and Opioid Use (21 papers). Lewei Lin collaborates with scholars based in United States, Taiwan and Australia. Lewei Lin's co-authors include Amy S. B. Bohnert, Mark A. Ilgen, Frederic C. Blow, Donovan T. Maust, Jason E. Goldstick, Rebecca L. Haffajee, Kipling M. Bohnert, Matthew A. Davis, Haiyin Liu and Brian D. Sites and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and JNCI Journal of the National Cancer Institute.

In The Last Decade

Lewei Lin

73 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder

2019 191 citations Lewei Lin, Amy S. B. Bohnert et al. JAMA Network Open profile →

Peers

Lewei Lin

PHEOH

EPIDE

PHARM

GHP

Jennifer Sharpe Potter United States

Adrian Dunlop Australia

Jeanette M. Tetrault United States

Travis I. Lovejoy United States

Genie L. Bailey United States

Marica Ferri Portugal

Debra S. Herman United States

Erin L. Winstanley United States

Daniel P. Alford United States

Kenneth B. Stoller United States

Jennifer Sharpe Potter United States

Lewei Lin

1.6k ×1.3

PHEOH

1.2k ×1.5

EPIDE

468 ×1.1

PHARM

408 ×1.2

GHP

471 ×1.4

Citations per year, relative to Lewei Lin Lewei Lin (= 1×) peers Jennifer Sharpe Potter

Countries citing papers authored by Lewei Lin

Since Specialization

Citations

This map shows the geographic impact of Lewei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewei Lin more than expected).

Fields of papers citing papers by Lewei Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewei Lin. The network helps show where Lewei Lin may publish in the future.

Co-authorship network of co-authors of Lewei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lewei Lin. A scholar is included among the top collaborators of Lewei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewei Lin. Lewei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hellman, L, et al.. (2025). The path forward for substance use disorder treatment using contingency management under sect. 1115 demonstration waivers. Substance Abuse Treatment Prevention and Policy. 20(1). 37–37.

Florimbio, Autumn Rae, et al.. (2025). Patient perspectives on medications for alcohol use disorder: A systematic scoping review. Alcohol Clinical and Experimental Research. 49(4). 725–735. 1 indexed citations

Howell, Benjamin A., Lewei Lin, & Lara N. Coughlin. (2024). Treatment for Co-Occurring Stimulant and Opioid Use Disorders. JAMA Psychiatry. 81(9). 853–853. 1 indexed citations

Frost, Madeline C., Lara N. Coughlin, Lan Zhang, & Lewei Lin. (2024). Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration. Journal of Addiction Medicine. 18(5). 561–566. 3 indexed citations

Coughlin, Lara N., Madeline C. Frost, Lan Zhang, & Lewei Lin. (2023). Impact of COVID-19 on stimulant use disorder treatment: A national cohort study in the Veterans Health Administration. Drug and Alcohol Dependence. 252. 110965–110965. 3 indexed citations

Florimbio, Autumn Rae, Maureen A. Walton, Lara N. Coughlin, Lewei Lin, & Erin E. Bonar. (2023). Perceived risk of harm for different methods of cannabis consumption: A brief report. Drug and Alcohol Dependence. 251. 110915–110915. 9 indexed citations

Chen, Liying, Christopher Frank, Jason E. Goldstick, et al.. (2023). Prescriptions for Buprenorphine in Michigan Following an Education Intervention. JAMA Network Open. 6(12). e2349103–e2349103. 2 indexed citations

Christine, Paul J., et al.. (2023). Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA Health Forum. 4(10). e233549–e233549. 7 indexed citations

Lin, Chunqing, Yuhui Zhu, Lewei Lin, et al.. (2022). Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug and Alcohol Dependence. 242. 109711–109711. 21 indexed citations

10.

Lagisetty, Pooja, et al.. (2021). Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug and Alcohol Dependence. 221. 108583–108583. 63 indexed citations

11.

Bicket, Mark C., Lewei Lin, & Jennifer F. Waljee. (2021). New Persistent Opioid Use After Surgery. Annals of Surgery. Publish Ahead of Print. 1 indexed citations

12.

Coughlin, Lara N., Lewei Lin, Mary Jannausch, Mark A. Ilgen, & Erin E. Bonar. (2021). Methamphetamine use among American Indians and Alaska Natives in the United States. Drug and Alcohol Dependence. 227. 108921–108921. 11 indexed citations

13.

Tang, Ruiqi, Katherine B. Santosa, Joceline V. Vu, et al.. (2020). Preoperative Opioid Use and Readmissions Following Surgery. Annals of Surgery. 275(1). e99–e106. 22 indexed citations

14.

Knudsen, Hannah K., Michelle R. Lofwall, Lewei Lin, Sharon Walsh, & Jamie L. Studts. (2019). US physicians’ decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progress. Drug and Alcohol Dependence. 204. 107490–107490. 3 indexed citations

15.

Lin, Lewei, Michelle R. Lofwall, Sharon Walsh, Adam J. Gordon, & Hannah K. Knudsen. (2018). Perceptions and practices addressing diversion among US buprenorphine prescribers. Drug and Alcohol Dependence. 186. 147–153. 34 indexed citations

16.

Davis, Alan K., Lewei Lin, Mark A. Ilgen, & Kipling M. Bohnert. (2017). Recent cannabis use among Veterans in the United States: Results from a national sample. Addictive Behaviors. 76. 223–228. 42 indexed citations

17.

Lin, Lewei, Avinash Hosanagar, Tae Woo Park, & Amy S. B. Bohnert. (2016). Opioid Overdose: Risk Assessment and Mitigation in Outpatient Treatment. Journal of Addiction Medicine. 10(6). 382–386. 2 indexed citations

18.

Park, Tae Woo, et al.. (2016). Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy. Journal of Addiction Medicine. 10(6). 369–381. 59 indexed citations

19.

Lin, Lewei, et al.. (2015). Pain acceptance and opiate use disorders in addiction treatment patients with comorbid pain. Drug and Alcohol Dependence. 157. 136–142. 15 indexed citations

20.

Öngür, Döst, Lewei Lin, & Bruce M. Cohen. (2008). Clinical characteristics influencing age at onset in psychotic disorders. Comprehensive Psychiatry. 50(1). 13–19. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact